This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, L.
Right arrow Articles by Kovacs, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, L.
Right arrow Articles by Kovacs, J. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2000, p. 3092-3096, Vol. 44, No. 11
0066-4804/00/$04.00+0

Expression and Characterization of Recombinant Human-Derived Pneumocystis carinii Dihydrofolate Reductase

Liang Ma and Joseph A. Kovacs*

Critical Care Medicine Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland

Received 23 May 2000/Returned for modification 27 June 2000/Accepted 1 August 2000

Dihydrofolate reductase (DHFR) is the target of trimethoprim (TMP), which has been widely used in combination with sulfa drugs for treatment and prophylaxis of Pneumocystis carinii pneumonia. While the rat-derived P. carinii DHFR has been well characterized, kinetic studies of human-derived P. carinii DHFR, which differs from rat-derived P. carinii DHFR by 38% in amino acid sequence, have not been reported to date. Here we report on the expression and kinetic characterization of the recombinant human-derived P. carinii DHFR. The 618-bp coding sequence of the human-derived P. carinii DHFR gene was expressed in Escherichia coli. As determined by sodium dodecyl sulfate-polyacrylamide gel eletrophoresis, the purified enzyme had a molecular mass of 25 kDa, consistent with that predicted from the DNA sequence. Kinetic analysis showed that the Km values for dihydrofolate and NADPH were 2.7 ± 0.3 and 14.0 ± 4.3 µM, respectively, which are similar to those reported for rat-derived P. carinii DHFR. Inhibition studies revealed that both TMP and pyrimethamine were poor inhibitors of human-derived P. carinii DHFR, with Ki values of 0.28 ± 0.08 and 0.065 ± 0.005 µM, respectively, while trimetrexate and methotrexate were potent inhibitors, with Ki values of 0.23 ± 0.03 and 0.016 ± 0.004 nM, respectively. The availability of purified recombinant enzyme in large quantities should facilitate the identification of antifolate inhibitors with greater potency and higher selectivity for human-derived P. carinii DHFR.


* Corresponding author. Mailing address: Building 10, Room 7D43, National Institutes of Health, 10 Center Dr. MSC 1662, Bethesda, MD 20892-1662. Phone: (301) 496-9907. Fax: (301) 402-1213. E-mail: jkovacs{at}nih.gov.


Antimicrobial Agents and Chemotherapy, November 2000, p. 3092-3096, Vol. 44, No. 11
0066-4804/00/$04.00+0



This article has been cited by other articles:

  • Liu, J., Bolstad, D. B., Bolstad, E. S. D., Wright, D. L., Anderson, A. C. (2009). Towards New Antifolates Targeting Eukaryotic Opportunistic Infections. Eukaryot Cell 8: 483-486 [Abstract] [Full Text]  
  • Costa, M. C., Esteves, F., Antunes, F., Matos, O. (2006). Genetic characterization of the dihydrofolate reductase gene of Pneumocystis jirovecii isolates from Portugal. J Antimicrob Chemother 58: 1246-1249 [Abstract] [Full Text]  
  • Nahimana, A., Rabodonirina, M., Bille, J., Francioli, P., Hauser, P. M. (2004). Mutations of Pneumocystis jirovecii Dihydrofolate Reductase Associated with Failure of Prophylaxis. Antimicrob. Agents Chemother. 48: 4301-4305 [Abstract] [Full Text]  
  • Ma, L., Jia, Q., Kovacs, J. A. (2002). Development of a Yeast Assay for Rapid Screening of Inhibitors of Human-Derived Pneumocystis carinii Dihydrofolate Reductase. Antimicrob. Agents Chemother. 46: 3101-3103 [Abstract] [Full Text]  
  • TAKAHASHI, T., ENDO, T., NAKAMURA, T., SAKASHITA, H., KIMURA, K., OHNISHI, K., KITAMURA, Y., IWAMOTO, A. (2002). Dihydrofolate reductase gene polymorphisms in Pneumocystis carinii f. sp. hominis in Japan. J Med Microbiol 51: 510-515 [Abstract] [Full Text]